Shete M, Kamble P, Patil K, Bhagawati B, Brahmankar U, Sharma M
Cureus. 2025; 17(2):e78481.
PMID: 40062078
PMC: 11885211.
DOI: 10.7759/cureus.78481.
Chellapandian N, Sekizhar V, Ammayappan P, Srivastava K, Nagy A, Kengadaran S
J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4289-S4298.
PMID: 40061634
PMC: 11888695.
DOI: 10.4103/jpbs.jpbs_1313_24.
Sun H, Yang C, Yin X, Chen S, Huang Y, Kuang H
Sci Rep. 2025; 15(1):7563.
PMID: 40038412
PMC: 11880343.
DOI: 10.1038/s41598-025-91207-5.
Narvekar S, Baliga S, Angadi P
J Oral Biol Craniofac Res. 2025; 15(2):383-389.
PMID: 40034371
PMC: 11872489.
DOI: 10.1016/j.jobcr.2025.02.002.
Qamar R, Khatoon A, Mirza T, Razi A, Khurshid Y
Odontology. 2025; .
PMID: 39994129
DOI: 10.1007/s10266-025-01074-9.
Oral submucous fibrosis: pathogenesis and therapeutic approaches.
Tang J, Liu J, Zhou Z, Cui X, Tu H, Jia J
Int J Oral Sci. 2025; 17(1):8.
PMID: 39890798
PMC: 11785813.
DOI: 10.1038/s41368-024-00344-6.
Adipose-derived stem cell exosomes attenuates myofibroblast transformation via inhibiting autophagy through TGF-β/Smad2 axis in oral submucosal fibrosis.
Xu J, Wang Y, Shao Z, Zhou Y, Bin X, Liu L
J Nanobiotechnology. 2024; 22(1):780.
PMID: 39702233
PMC: 11658435.
DOI: 10.1186/s12951-024-03067-2.
Prevalence of oral submucous fibrosis across diverse populations: a systematic review and meta-analysis.
Wang M, Duan C, Wei Y, Xu X
PeerJ. 2024; 12:e18385.
PMID: 39525471
PMC: 11549909.
DOI: 10.7717/peerj.18385.
Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma.
Mitea G, Schroder V, Iancu I, Miresan H, Iancu V, Bucur L
Cancers (Basel). 2024; 16(21).
PMID: 39518052
PMC: 11545343.
DOI: 10.3390/cancers16213612.
Diagnostic potential of salivary IL-1β, IL-8, SAT, S100P, and OAZ1 in oral squamous cell carcinoma, oral submucous fibrosis, and oral lichen planus based on findings from a Sri Lankan cohort.
Senevirathna K, Mahakapuge T, Jayawardana N, Rajapakse J, Gamage C, Seneviratne B
Sci Rep. 2024; 14(1):27226.
PMID: 39516476
PMC: 11549458.
DOI: 10.1038/s41598-024-75735-0.
MicroRNA-503 Suppresses Oral Mucosal Fibroblast Differentiation by Regulating RAS/RAF/MEK/ERK Signaling Pathway.
Wen D, Zhang H, Zhou Y, Jian N, Jiang C, Wang J
Biomolecules. 2024; 14(10).
PMID: 39456192
PMC: 11505938.
DOI: 10.3390/biom14101259.
Mechanism of curcumin in the prevention and treatment of oral submucosal fibrosis and progress in clinical application research.
She R, Xu P
BDJ Open. 2024; 10(1):82.
PMID: 39455570
PMC: 11512022.
DOI: 10.1038/s41405-024-00268-7.
Role of mast cells in the pathogenesis of oral submucous fibrosis: a systematic review and meta-analysis.
Bijai L, Aboalela A, Albalawi F, Khanagar S, Iyer K
BMC Oral Health. 2024; 24(1):1219.
PMID: 39402549
PMC: 11476548.
DOI: 10.1186/s12903-024-05025-8.
Comprehensive analysis of clinicopathological characteristics in oral squamous cell carcinoma arising from oral submucous fibrosis: a retrospective study.
Zeng Y, Luo J, Zi M, Jiang S, Ge W, Yu Y
Discov Oncol. 2024; 15(1):455.
PMID: 39289291
PMC: 11408422.
DOI: 10.1007/s12672-024-01351-z.
The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer.
Talapko J, Eric S, Mestrovic T, Stipetic M, Juzbasic M, Katalinic D
Cancers (Basel). 2024; 16(17).
PMID: 39272855
PMC: 11394246.
DOI: 10.3390/cancers16172997.
Salivary Profile in Oral Submucous Fibrosis: A Scoping Review.
Mahdani F, Subarnbhesaj A, Ayuningtyas N, Surboyo M, Bakti R, Radithia D
Eur J Dent. 2024; 19(1):24-36.
PMID: 39102860
PMC: 11750339.
DOI: 10.1055/s-0044-1788711.
Effect of Jiedu Huayu decoction on oral mucosal Axin and β-catenin expression in oral submucosal fibrosis model rats.
Xuan Z, An L, Keke Z, Mingyu R
J Tradit Chin Med. 2024; 44(4):688-693.
PMID: 39066529
PMC: 11337252.
DOI: 10.19852/j.cnki.jtcm.20240617.001.
Computational analysis of phytocompounds in for its antifibrotic and drug-likeness properties - Herb to drug study.
Gayathri K, Abhinand P, Gayathri V, Prasanna Lakshmi V, Chamundeeswari D, Jiang L
Heliyon. 2024; 10(13):e33762.
PMID: 39027607
PMC: 11255509.
DOI: 10.1016/j.heliyon.2024.e33762.
SFRP1 reduces neutrophil infiltration and inhibits the Wnt/β-catenin pathway to alleviate oral submucous fibrosis.
Zhou R, Yin L, Zhang X, Zhu K
In Vitro Cell Dev Biol Anim. 2024; 60(9):1034-1045.
PMID: 39017751
DOI: 10.1007/s11626-024-00945-9.
Elongated Styloid Process Evaluation Using Panoramic Radiography in Patients With Oral Submucous Fibrosis: A Retrospective Study.
Evanjelin P, Tn U
Cureus. 2024; 16(5):e60781.
PMID: 38903350
PMC: 11188970.
DOI: 10.7759/cureus.60781.